Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 13, 2021 16:05 ET | Source: ClearPoint Neuro, Inc.

ClearPoint Neuro, Inc. Announces Retirement of Director John N. Spencer, Jr.

SOLANA BEACH, Calif., April 13, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
April 06, 2021 16:05 ET | Source: ClearPoint Neuro, Inc.

ClearPoint Neuro, Inc. Congratulates uniQure on Completion of Enrollment in First Cohort of Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntington’s Disease

IRVINE, Calif., April 06, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain,...
March 24, 2021 16:05 ET | Source: ClearPoint Neuro, Inc.

ClearPoint Neuro, Inc. Announces Appointment of Ellisa Cholapranee as General Counsel

IRVINE, Calif., March 24, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain,...
March 04, 2021 16:05 ET | Source: ClearPoint Neuro, Inc.

ClearPoint Neuro Reports Fourth Quarter and Full-Year 2020 Results

Company Reports Record Revenues IRVINE, Calif., March 04, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing...
February 23, 2021 16:05 ET | Source: ClearPoint Neuro, Inc.

ClearPoint Neuro Announces Closing of Public Offering of 2,127,660 Shares of Common Stock

IRVINE, Calif., Feb. 23, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain,...
February 19, 2021 16:05 ET | Source: ClearPoint Neuro, Inc.

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2020 Results on March 4, 2021

IRVINE, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain,...
February 18, 2021 22:10 ET | Source: ClearPoint Neuro, Inc.

ClearPoint Neuro Announces Pricing of Public Offering of 1,850,140 Shares of Common Stock

IRVINE, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain,...
February 18, 2021 16:35 ET | Source: ClearPoint Neuro, Inc.

ClearPoint Neuro Launches Proposed Public Offering of Common Stock

IRVINE, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain,...
February 18, 2021 16:05 ET | Source: ClearPoint Neuro, Inc.

ClearPoint Neuro, Inc. Announces License and Research Agreement with Philips

Collaboration will Enable ClearPoint to Develop and Launch the ClearPoint ‘Maestro™’ Brain Model by 2022 IRVINE, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT)...
February 11, 2021 16:05 ET | Source: ClearPoint Neuro, Inc.

ClearPoint Neuro, Inc. Announces Multi-Product Joint Development & Option Agreement with Blackrock Microsystems

IRVINE, Calif. and SALT LAKE CITY, Utah, Feb. 11, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and...